ECR 2013 – Final Programme - myESR.org

Scientific Sessions15:03B-0487 Validity of gradient-echo three-dimensional delayedgadolinium-enhanced magnetic resonance imaging ofhip joint cartilage: a histologically controlled studyC. Zilkens 1 , F.R. Miese 1 , M. Herten 1 , S. Kurzidem 1 , M. Jäger 2 , D. König 3 ,G. Antoch 1 , R. Krauspe 1 , B. Bittersohl 1 ; 1 Düsseldorf/DE, 2 Essen/DE, 3 Viersen/DE15:12B-0488 In-vivo sodium magnetic resonance (MR) imaging ofhealthy intervertebral discs during unloadingK.M. Friedrich, J. Wimmer, V. Juras, S. Zbyn, I. Nöbauer-Huhmann, S. Trattnig;Vienna/AT15:21B-0489 T2 mapping for assessment of lumbar disc repair afterautologous disc-derived chondrocyte transplantation(ADCT)M. Glowacki, M. Ostrowska, W. Gradkowski, J. Walecki; Warsaw/PL15:03B-0497 Uterine artery embolization for management ofsecondary postpartum haemorrhage associated withplacenta accretaZ. Wang, Z. Jin, X. Li; Beijing/CN15:12B-0498 Placenta percreta: role of bilateral occlusion balloonsinsertion in to internal iliac arteries to preventhaemorrhage and hysterectomyM. Teixidor Viñas, A.-M. Belli, E. Chandraharan; London/UK15:21B-0499 Efficacy of bilateral uterine artery embolization asa first-line therapeutic option for acquired uterinearteriovenous malformationsJ. Shin, H.-K. Yoon, G.-Y. Ko, D.-I. Gwon; Seoul/KRB-0487 – B-050614:00–15:30 Room PInterventional RadiologySS 609b Gynaecological and obstetricinterventionsModerators: P. Andersen; Odense/DK, R. Nijenhuis; Maastricht/NL14:00B-0490 Non-invasive treatment of uterine fibroids using MRguidedhigh-intensity focused ultrasound: results onquality of life, non-perfused volume ratio and sizereduction over 12 monthsF. Ciolina, A. Napoli, B. Cavallo Marincola, F. Boni, F. Zaccagna, V. Noce,L. Bertaccini, C. Catalano; Rome/IT14:09B-0491 MRI-guided focused ultrasound treatment ofsymptomatic uterine fibroids: impact of technologyadvancement on ablation volumes in 115 patientsC.G. Trumm 1 , R. Stahl 1 , D.-A. Clevert 1 , P. Herzog 2 , I. Mindjuk 2 , S. Kornprobst 2 , R.-T. Hoffmann 3 , M.F. Reiser 1 , M. Matzko 2 ; 1 Munich/DE, 2 Dachau/DE, 3 Dresden/DE14:18B-0492 Efficacy of MRI-guided focused ultrasound (MRgFUS)treatment of uterine fibroids: evaluation of nonperfusedvolume (NPV), fibroid shrinkage and clinicalimprovement at 6-month follow-upI. Invernizzi 1 , M. Vaiani 1 , P. Colombo 1 , F. Zucconi 1 , S. Sironi 2 , C. Ticca 1 ; 1 Milan/IT,2Monza/IT14:27B-0493 Uterine adenomyosis treated by MRgFUS: technicalapproach and clinical resultsF. Ferrari, A. Miccoli, F. Arrigoni, A.V. Giordano, E. Fascetti, G. Mascaretti,C. Masciocchi; L‘Aquila/IT14:36B-0494 Is uterine artery embolisation in large sized myomaas efficient as in normal sized myoma: a retrospectivecomparative study in 263 patientsH. Choi 1 , G. Jeon 1 , M. Kim 2 , J. Lee 1 , J. Yoon 1 , S. Hwang 1 ; 1 Seongnam/KR,2Seoul/KR14:45B-0495 Usefulness of pelvic artery embolisation: acomparison between caesarean section and vaginaldelivery in 176 patientsH. Lee, G. Jeon; Seongnam-si/KR14:54B-0496 Transarterial embolization in the treatment ofpostpartum haemorrhageZ. Wang, X. Li, Z. Jin; Beijing/CN14:00–15:30 Room ZMolecular ImagingSS 606 MR/PET and PET/CTModerators: N. Belcari; Pisa/IT, P.R. Ros; Cleveland, OH/US14:00B-0500 Simultaneous 68 Ga-DOTATOC PET/MRI for whole bodystaging in patients with neuroendocrine tumours:preliminary resultsK.J. Beiderwellen 1 , T.D. Poeppel 1 , V. Hartung-Knemeyer 1 , C. Buchbender 2 ,H. Kuehl 1 , A. Bockisch 1 , T.C. Lauenstein 1 ; 1 Essen/DE, 2 Düsseldorf/DE14:09B-0501 Diffusion-weighted imaging as part of hybrid FDG-PET/MRI protocols for whole body cancer staging: does itbenefit lesion detection?T.A. Heusner 1 , P. Heusch 1 , V. Hartung-Knemeyer 2 , K. Beiderwellen 2 ,T. Lauenstein 2 , M. Forsting 2 , G. Antoch 1 , C. Buchbender 1 ; 1 Düsseldorf/DE,2Essen/DE14:18B-0502 Molecular imaging of the prostate usingmultiparametric functional [11C]-acetate PET/MRI:proof of conceptS. Polanec, T. Helbich, K. Pinker-Domenig, S. Leitner, B. Füger, G. Karanikas,M. Margreiter, S. Kommata, P. Brader; Vienna/AT14:27B-0503 PET/CT guided therapy planning in prostate cancerpatients eligible for radiotherapy: results from abicentric clinical studyE. Lopci 1 , B.A. Jereczek-Fossa 2 , M. Rodari 1 , G. Pepe 1 , C. Fodor 2 , D. Zerini 2 , O. DeCobelli 2 , R. Orecchia 2 , A. Chiti 1 ; 1 Rozzano/IT, 2 Milan/IT14:36B-0504 Detection of lung nodules in an integrated whole bodyMR/PET scanner: comparison to PET/CTN.F. Schwenzer, C. Schraml, S. Gatidis, C. Brendle, H. Schmidt, C. Pfannenberg,C.D. Claussen; Tübingen/DE14:45B-0505 Assessment of tumour aggressiveness withquantitative perfusion imaging and tumour volume inpatients with lung cancer: correlation with metabolicparameters of 18 FDG-PET/CTD. Fior, D. Ippolito, P.A. Bonaffini, C. Capraro, C. Messa, S. Sironi; Monza/IT14:54B-0506 FDG-PET/CT for the early prediction ofhistopathological complete response to neoadjuvantchemotherapy in breast cancer patientsT.A. Heusner 1 , C. Riegger 1 , S. Kuemmel 2 , M. Forsting 2 , V. Hartung-Knemeyer 2 ,G. Antoch 1 , C. Buchbender 1 ; 1 Düsseldorf/DE, 2 Essen/DEFriday239